July 29, 2016 10:38 AM ET

Biotechnology

Company Overview of Inimex Pharmaceuticals Inc.

Key Executives for Inimex Pharmaceuticals Inc.

NameBoard RelationshipsTitleAge
Michael J. Abrams Ph.D.42 RelationshipsChief Executive Officer, President and Director60
B. Brett Finlay Ph.D., O.C., F.R.S.C.29 RelationshipsCo-Founder and Chairman of Scientific Advisory Board--
Martin McConnell C.A.No RelationshipsChief Financial Officer--
Monisha Scott No RelationshipsDirector of Target Discovery and Validation--
Jeff Wilson No RelationshipsVice President of Product Development--

Inimex Pharmaceuticals Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Robert A. Fildes Ph.D. 16 RelationshipsInimex Pharmaceuticals Inc.77
Michael J. Abrams Ph.D. 42 RelationshipsArbutus Biopharma Corporation60
B. Brett Finlay Ph.D., O.C., F.R.S.C. 29 RelationshipsPureTech Health plc--
H. Grant Stiver M.D. 16 RelationshipsInimex Pharmaceuticals Inc.--
Brenda Irwin MBA 18 RelationshipsRelentless Pursuits Partners, Inc.--
View All Board Members

Inimex Pharmaceuticals Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D., O.C., F.R.S.C.B. Brett Finlay29 Relationships12 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
380.7K
Bonus
261.1K
Total Short Term Compensation
475.5K
Total Value of Options
34.0M
Compensation as of Fiscal Year
Inimex Pharmaceuticals Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Spring Bank Pharmaceuticals, Inc. Appoints Todd C. Brady to the Company's Board of Directors
July 28, 2016 8:05 PM ET
U.S. Stem Cell, Inc. Announces Resignation of Sam Ahn as Member of the Board of Directors
July 28, 2016 8:03 PM ET
Provista Diagnostics Appoints Judith K. Wolf as Chief Medical Officer
July 28, 2016 1:00 PM ET
Seattle Genetics Announces Executive Changes
July 27, 2016 10:43 PM ET
Advanced Accelerator Applications S.A. Appoints Francois Nader as an Independent Non-Executive Director Replacing Muriel De Szilbereky
July 27, 2016 9:10 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Inimex Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.